INOGEN, INC. Revenue
INOGEN, INC. (INGN) reported Revenue of $95.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Revenue
us-gaap:Revenues · last filed 2026-08-07
- INOGEN, INC. revenues for the quarter ending 2026-06-30 was $95.08M, a 3.04% increase year-over-year.
- INOGEN, INC. revenues for the quarter ending 2026-03-31 was $85.11M, a 3.44% increase year-over-year.
- INOGEN, INC. revenues for the quarter ending 2025-12-31 was $81.72M, a 2.05% increase year-over-year.
- INOGEN, INC. revenues for the quarter ending 2025-09-30 was $92.39M, a 4.00% increase year-over-year.
- INOGEN, INC. revenues for fiscal 2025 was $348.67M, a 3.86% increase from fiscal 2024.
- INOGEN, INC. revenues for fiscal 2024 was $335.70M, a 6.35% increase from fiscal 2023.
- INOGEN, INC. revenues for fiscal 2023 was $315.66M, a 16.32% decline from fiscal 2022.
- INOGEN, INC. revenues for fiscal 2022 was $377.24M, a 5.37% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $95.08M 10-Q · filed 2026-08-07 | $180.19M 10-Q · filed 2026-08-07 | $261.91M derived: sum of 3 quarters · filed 2026-08-07 | $354.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $85.11M 10-Q · filed 2026-05-08 | $166.83M derived: sum of 2 quarters · filed 2026-05-08 | $259.22M derived: sum of 3 quarters · filed 2026-05-08 | $351.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $81.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $174.11M derived: sum of 2 quarters · filed 2026-02-27 | $266.39M derived: sum of 3 quarters · filed 2026-08-07 | $348.67M 10-K · filed 2026-02-27 |
| 2025-09-30 | $92.39M 10-Q · filed 2025-11-06 | $184.67M derived: sum of 2 quarters · filed 2026-08-07 | $266.95M 10-Q · filed 2025-11-06 | $347.03M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $92.28M 10-Q · filed 2026-08-07 | $174.56M 10-Q · filed 2026-08-07 | $254.64M derived: sum of 3 quarters · filed 2026-08-07 | $343.47M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $82.28M 10-Q · filed 2026-05-08 | $162.36M derived: sum of 2 quarters · filed 2026-05-08 | $251.19M derived: sum of 3 quarters · filed 2026-05-08 | $339.96M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $80.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $168.91M derived: sum of 2 quarters · filed 2026-02-27 | $257.68M derived: sum of 3 quarters · filed 2026-02-27 | $335.70M 10-K · filed 2026-02-27 |
| 2024-09-30 | $88.83M 10-Q · filed 2025-11-06 | $177.60M derived: sum of 2 quarters · filed 2025-11-06 | $255.62M 10-Q · filed 2025-11-06 | $331.52M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $88.77M 10-Q · filed 2025-08-08 | $166.79M 10-Q · filed 2025-08-08 | $242.69M derived: sum of 3 quarters · filed 2026-02-27 | $326.65M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $78.03M 10-Q · filed 2025-05-08 | $153.92M derived: sum of 2 quarters · filed 2026-02-27 | $237.89M derived: sum of 3 quarters · filed 2026-02-27 | $321.52M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $75.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $159.86M derived: sum of 2 quarters · filed 2026-02-27 | $243.50M derived: sum of 3 quarters · filed 2026-02-27 | $315.66M 10-K · filed 2026-02-27 |
| 2023-09-30 | $83.97M 10-Q · filed 2024-11-08 | $167.60M derived: sum of 2 quarters · filed 2024-11-08 | $239.76M 10-Q · filed 2024-11-08 | $327.86M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $83.64M 10-Q · filed 2024-08-07 | $155.80M 10-Q · filed 2024-08-07 | $243.89M derived: sum of 3 quarters · filed 2025-02-28 | $349.28M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $72.16M 10-Q · filed 2024-05-08 | $160.25M derived: sum of 2 quarters · filed 2025-02-28 | $265.64M derived: sum of 3 quarters · filed 2025-02-28 | $369.02M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $88.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $193.48M derived: sum of 2 quarters · filed 2025-02-28 | $296.86M derived: sum of 3 quarters · filed 2025-02-28 | $377.24M 10-K · filed 2025-02-28 |
| 2022-09-30 | $105.39M 10-Q · filed 2023-11-09 | $208.76M derived: sum of 2 quarters · filed 2023-11-09 | $289.15M 10-Q · filed 2023-11-09 | $365.55M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-06-30 | $103.38M 10-Q · filed 2023-08-08 | $183.76M 10-Q · filed 2023-08-08 | $260.16M derived: sum of 3 quarters · filed 2024-03-01 | $353.27M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-03-31 | $80.39M 10-Q · filed 2023-05-05 | $156.79M derived: sum of 2 quarters · filed 2024-03-01 | $249.89M derived: sum of 3 quarters · filed 2024-03-01 | $351.46M derived: sum of 4 quarters · filed 2024-03-01 |
| 2021-12-31 | $76.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $169.51M derived: sum of 2 quarters · filed 2024-03-01 | $271.07M derived: sum of 3 quarters · filed 2024-03-01 | $358.00M 10-K · filed 2024-03-01 |
| 2021-09-30 | $93.11M 10-Q · filed 2022-11-03 | $194.67M derived: sum of 2 quarters · filed 2022-11-03 | $281.60M 10-Q · filed 2022-11-03 | $355.58M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $101.56M 10-Q · filed 2022-08-04 | $188.50M 10-Q · filed 2022-08-04 | $262.47M derived: sum of 3 quarters · filed 2022-08-04 | $336.80M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $86.93M 10-Q · filed 2022-05-05 | $160.91M derived: sum of 2 quarters · filed 2022-05-05 | $235.24M derived: sum of 3 quarters · filed 2022-05-05 | $306.93M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $73.98M 10-K · filed 2021-02-24 | $148.31M derived: sum of 2 quarters · filed 2021-11-04 | $220.00M derived: sum of 3 quarters · filed 2021-11-04 | $308.49M 10-K · filed 2023-02-24 |
| 2020-09-30 | $74.33M 10-Q · filed 2021-11-04 | $146.02M derived: sum of 2 quarters · filed 2021-11-04 | $234.51M 10-Q · filed 2021-11-04 | $313.43M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $71.69M 10-Q · filed 2021-08-04 | $160.18M 10-Q · filed 2021-08-04 | $239.10M derived: sum of 3 quarters · filed 2021-08-04 | $330.86M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $88.49M 10-Q · filed 2021-05-04 | $167.41M derived: sum of 2 quarters · filed 2021-05-04 | $259.17M derived: sum of 3 quarters · filed 2021-05-04 | $360.23M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $78.92M 10-K · filed 2021-02-24 | $170.68M derived: sum of 2 quarters · filed 2021-02-24 | $271.74M derived: sum of 3 quarters · filed 2021-02-24 | $361.94M 10-K · filed 2022-02-24 |
| 2019-09-30 | $91.76M 10-K · filed 2021-02-24 | $192.82M derived: sum of 2 quarters · filed 2021-02-24 | $283.03M 10-Q · filed 2020-11-04 | $369.56M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $101.06M 10-K · filed 2021-02-24 | $191.26M 10-Q · filed 2020-08-04 | $277.80M derived: sum of 3 quarters · filed 2021-02-24 | $373.09M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $90.20M 10-K · filed 2021-02-24 | $176.73M derived: sum of 2 quarters · filed 2021-02-24 | $272.02M derived: sum of 3 quarters · filed 2021-02-24 | $369.26M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $86.53M 10-K · filed 2020-02-25 | $181.82M derived: sum of 2 quarters · filed 2020-02-25 | $279.06M derived: sum of 3 quarters · filed 2020-02-25 | $358.11M 10-K · filed 2021-02-24 |
| 2018-09-30 | $95.29M 10-K · filed 2020-02-25 | $192.53M derived: sum of 2 quarters · filed 2020-02-25 | $271.58M 10-Q · filed 2019-11-05 | $335.37M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $97.24M 10-K · filed 2020-02-25 | $176.29M 10-Q · filed 2019-08-07 | $240.08M derived: sum of 3 quarters · filed 2020-02-25 | $309.11M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $79.05M 10-K · filed 2020-02-25 | $142.84M derived: sum of 2 quarters · filed 2020-02-25 | $211.87M derived: sum of 3 quarters · filed 2020-02-25 | $275.99M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $63.79M 10-K · filed 2019-02-26 | $132.82M derived: sum of 2 quarters · filed 2019-02-26 | $196.94M derived: sum of 3 quarters · filed 2019-02-26 | $249.44M 10-K · filed 2020-02-25 |
| 2017-09-30 | $69.03M 10-K · filed 2019-02-26 | $133.15M derived: sum of 2 quarters · filed 2019-02-26 | $185.65M 10-Q · filed 2018-11-06 | $236.50M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $64.12M 10-K · filed 2019-02-26 | $116.62M 10-Q · filed 2018-08-07 | $167.47M derived: sum of 3 quarters · filed 2019-02-26 | $221.89M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $52.50M 10-K · filed 2019-02-26 | $103.35M derived: sum of 2 quarters · filed 2019-02-26 | $157.77M derived: sum of 3 quarters · filed 2019-02-26 | $212.34M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $50.85M 10-K · filed 2018-02-27 | $105.27M derived: sum of 2 quarters · filed 2018-02-27 | $159.84M derived: sum of 3 quarters · filed 2018-02-27 | $202.83M 10-K · filed 2019-02-26 |
| 2016-09-30 | $54.42M 10-K · filed 2018-02-27 | $108.99M derived: sum of 2 quarters · filed 2018-02-27 | $151.98M 10-Q · filed 2017-11-07 | $192.42M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $54.57M 10-K · filed 2018-02-27 | $97.56M 10-Q · filed 2017-08-03 | $138.00M derived: sum of 3 quarters · filed 2018-02-27 | $178.78M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $42.99M 10-K · filed 2018-02-27 | $83.44M derived: sum of 2 quarters · filed 2018-02-27 | $124.21M derived: sum of 3 quarters · filed 2018-02-27 | $168.24M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $40.45M 10-K · filed 2017-02-28 | $81.22M derived: sum of 2 quarters · filed 2017-02-28 | $125.25M derived: sum of 3 quarters · filed 2017-02-28 | $159.00M 10-K · filed 2018-02-27 |
| 2015-09-30 | $40.78M 10-K · filed 2017-02-28 | $84.81M derived: sum of 2 quarters · filed 2017-02-28 | $118.56M 10-Q · filed 2016-11-03 | $147.68M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $44.03M 10-K · filed 2017-02-28 | $77.78M 10-Q · filed 2016-08-04 | $106.90M derived: sum of 3 quarters · filed 2017-02-28 | $136.29M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $33.75M 10-K · filed 2017-02-28 | $62.87M derived: sum of 2 quarters · filed 2017-02-28 | $92.26M derived: sum of 3 quarters · filed 2017-02-28 | $122.66M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $29.12M 10-K · filed 2016-03-14 | $58.51M derived: sum of 2 quarters · filed 2016-03-14 | $88.90M derived: sum of 3 quarters · filed 2016-03-14 | $112.54M 10-K · filed 2017-02-28 |
| 2014-09-30 | $29.39M 10-K · filed 2016-03-14 | $59.79M derived: sum of 2 quarters · filed 2016-03-14 | $83.42M 10-Q · filed 2015-11-10 | $103.18M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $30.39M 10-K · filed 2016-03-14 | $54.03M 10-Q · filed 2015-08-11 | $73.79M derived: sum of 3 quarters · filed 2016-03-14 | $93.56M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $23.63M 10-K · filed 2016-03-14 | $43.40M derived: sum of 2 quarters · filed 2016-03-14 | $63.17M derived: sum of 3 quarters · filed 2016-03-14 | $83.33M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $19.76M 10-K · filed 2015-04-27 | $39.54M derived: sum of 2 quarters · filed 2015-04-27 | $59.70M derived: sum of 3 quarters · filed 2015-04-27 | $75.44M 10-K · filed 2016-03-14 |
| 2013-09-30 | $19.78M 10-K · filed 2015-04-27 | $39.93M derived: sum of 2 quarters · filed 2015-04-27 | $55.68M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $20.16M 10-K · filed 2015-04-27 | $35.90M 10-Q · filed 2014-08-12 | ||
| 2013-03-31 | $15.75M 10-K · filed 2015-04-27 | |||
| 2012-12-31 | $48.58M 10-K · filed 2015-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |